APP and Alzheimer disease: In fact, mutations that promote the amyloidogenic processing of APP are associated with AD (Mullan et al., 1992; Pagnon de la Vega et al., 2021), whereas those that favor the alternative, non-amyloidogenic pathway protect against the disease (Tambini et al., 2020; Jansen et al., 2019).